The 17 analysts offering 1 year price forecasts for NZYM have a max estimate of — and a min estimate of —.
Analyst rating
Based on 19 analysts giving stock ratings to NZYM in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NZYM EPS for the last quarter is 0.36 EUR despite the estimation of 0.51 EUR. In the next quarter EPS is expected to reach 0.52 EUR. Track more of NOVOZYMES AS financials and stay on top of what is up with the company.
In the next quarter NOVOZYMES AS revenue is expected to reach 988.00 M EUR. Check out NOVOZYMES AS revenue and earnings and make informed decisions.
According to analysts, NZYM price target is 67.01 EUR with a max estimate of 80.18 EUR and a min estimate of 48.79 EUR. Check if this forecast comes true in a year, meanwhile watch NOVOZYMES AS stock price chart and keep track of the current situation with NZYM news and stock market news.
We've gathered opinions of 19 analysts rating NZYM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.